Earnings history

last 4 reports each · paired by recencyMethod

BCAB

No earnings history for BCAB.

AMGN

4 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±3.7%+3.73%×1.00

Q2 FY26±4.1%+4.57%×1.12

Q1 FY26±3.9%−4.75%×1.23

Feb 4 '26±3.7%+8.15%×2.22

= impliedBCAB realized, solidAMGN realized, hatchedOne scale, both sides: full bar = 9%× = |realized| ÷ impliedSource: market data

BCABBioAtla, Inc.

Mkt cap$3.3MRevenue$7MQ2 FY26Revenue—

AMGNAmgen Inc

460.55+0.06%· post 460.42

ClosedNov 6 '26

Mkt cap$249.0BRevenue$10.4BQ3 FY26Revenue$36.8BFY25

vs

Compare

ClosedNov 6 '26

BCABBioAtla, Inc.

vs

AMGNAmgen Inc

Price

460.55+0.06%post 460.42

$3.3M

Mkt cap

$249.0B

Q2 FY26$7M

Revenue

$10.4BQ3 FY26

—

Revenue

$36.8BFY25

BCAB compared with AMGN: revenue, margins and what each company keeps, and the suppliers and customers both name